GC
BOLD

Guggenheim Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Guggenheim Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,609
Closed -$276K – 2091
2019
Q4 		$276K Buy
+4,609
New +$173K ﹤0.01% 1864

Guggenheim Capital's BOLD Position: Q1 2020 in Review

Guggenheim Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 4,609 shares — an estimated $276K sold.

Guggenheim Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $276K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Guggenheim Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Guggenheim Capital sold 4,609 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $276K.
  • Guggenheim Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Guggenheim Capital's Audentes Therapeutics, Inc position peaked at $276K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Guggenheim Capital's 13F filing for Q1 2020, filed 2 Jun 2020.